In a lively debate, James Johnston MD, JD, and James Burke, MD, discussed whether neuroimaging is appropriate for patients with headache. Read more about their session at AAN’s 2019 Annual Meeting and post...
In a recent study, researchers reviewed the efficacy, safety, and cost-effectiveness of a combination therapy compared with levodopa/dopa-decarboxyiase inhibitor for the treatment of Parkinson disease. ...
Based on evidence from several clinical trials, an FDA advisory committee has voted unanimously to recommend the approval of a cannabis-based oral solution for the treatment of 2 rare forms of epilepsy. ...
Traumatic brain injury is known to be associated with dementia, but few large studies with long follow-up have been performed. In a study of nearly 3 million people with a risk for dementia, researchers...
Epilepsy is known to be associated with an increased risk of mortality, but less is known about the unnatural cause-specific risks of mortality in this patient population.
Using public health register and insurance data, the authors of a recent study investigated the risk of dementia and Alzheimer disease in 2 large cohorts of individuals who used antiepileptic drugs.
In a new study of participants from the Medication use and Alzheimer's disease cohort, researchers investigated the impact of opioid initiation on the prevalence of antipsychotic and benzodiazepine...
Findings from 2 trials that compared various doses of the atypical antipsychotic brexpiprazole with placebo have indicated that the drug may have additional benefits for patients with agitation due to...
